Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

86 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Comparison of Infectious Complications in Patients Receiving High-Dose Cyclophosphamide as GvHD Prophylaxis After Transplantation From A 9/10 HLA-Matched Unrelated Donor with Standard GvHD Prophylaxis After Transplant From A Fully Matched Related Donor.
Sayýn S, Yýldýrým M, Cömert M, Uğur B, Yýlmaz EŞ, Avcu F, Ural AU, Aylı M. Sayýn S, et al. Among authors: ayli m. Mediterr J Hematol Infect Dis. 2024 Mar 1;16(1):e2024016. doi: 10.4084/MJHID.2024.016. eCollection 2024. Mediterr J Hematol Infect Dis. 2024. PMID: 38468829 Free PMC article.
Treatment options in primary mediastinal B cell lymphoma patients, retrospective multicentric analysis; a Turkısh oncology group study.
Acar R, Paydaş S, Yıldırım M, Kılıçarslan E, Sahın U, Dogan A, Guven DC, Ekıncı O, Tıglıoglu M, Erdogan I, Elıbol T, Kızıloz H, Aykan MB, Sayın S, Kaptan K, Soydan E, Gokmen A, Esen R, Barısta I, Albayrak M, Erturk I, Yıldız B, Keskın GY, Aylı M, Karadurmus N. Acar R, et al. Among authors: ayli m. J Cancer Res Ther. 2023 Apr;19(Supplement):S138-S144. doi: 10.4103/jcrt.jcrt_355_22. J Cancer Res Ther. 2023. PMID: 37147993 Free article.
Immunosuppressive treatment results in patients with primary IgA nephropathy in Turkiye; the data from TSN-GOLD working group.
Oruc A, Sumnu A, Turkmen A, Basturk T, Cebeci E, Turgutalp K, Cetinkaya H, Uzerk Kibar M, Seyahi N, Tatar E, Ergul M, Derici Ü, Aylı MD, Pınar M, Bakar B, Kazancıoglu R, Yıldız A, Dirim AB, Yılmaz Z, Turkmen K, Tunca O, Koc M, Kutlay S, Micozkadıoglu H, Azak A, Boztepe B, Ustundag S, Şafak Ozturk S, Unsal A, Karadag S, Sahin G, Yenigun EC, Eren N, Gullulu M, Gursu M, Ozturk S. Oruc A, et al. Among authors: ayli md. Ren Fail. 2024 Dec;46(1):2341787. doi: 10.1080/0886022X.2024.2341787. Epub 2024 Apr 18. Ren Fail. 2024. PMID: 38637275 Free PMC article.
Management of Adult Primary Immune Thrombocytopenia: Delphi-Based Consensus Recommendations.
Demir AM, Ümit EG, Ar MC, Ayer M, Aylı M, Karakuş V, Kaya E, Özkalemkaş F, Sayınalp N, Sönmez M, Şahin F, Toprak SK, Toptaş T, Yavaşoğlu İ, Çalış Ü. Demir AM, et al. Among authors: ayli m. Turk J Haematol. 2024 Mar 28. doi: 10.4274/tjh.galenos.2024.2024.0055. Online ahead of print. Turk J Haematol. 2024. PMID: 38545671 Free article.
Comparison of homologous and heterologous inactivated and mRNA vaccination programme against SARS-CoV-2 in dialysis patients.
Yasar E, Yildiz Y, Ozturk E, Gok Oguz E, Coskun Yenigun E, Ozturk R, Helvaci O, Ozger HS, Keles M, Karacin C, Ugras Dikmen A, Caglar K, Duranay M, Ayli MD, Dizbay M, Erten Y, Guz G, Derici U. Yasar E, et al. Among authors: ayli md. Nephrology (Carlton). 2024 Mar 14. doi: 10.1111/nep.14292. Online ahead of print. Nephrology (Carlton). 2024. PMID: 38485143
A case with Joubert syndrome diagnosed at an advanced age.
Intas K, Ulusal Okyay G, Ayli MD. Intas K, et al. Among authors: ayli md. Med Clin (Barc). 2024 Apr 12;162(7):357-358. doi: 10.1016/j.medcli.2023.11.001. Epub 2023 Dec 19. Med Clin (Barc). 2024. PMID: 38123406 English, Spanish. No abstract available.
Efficacy and safety of the neonatal Fc receptor inhibitor efgartigimod in adults with primary immune thrombocytopenia (ADVANCE IV): a multicentre, randomised, placebo-controlled, phase 3 trial.
Broome CM, McDonald V, Miyakawa Y, Carpenedo M, Kuter DJ, Al-Samkari H, Bussel JB, Godar M, Ayguasanosa J, De Beuf K, Rodeghiero F, Michel M, Newland A; ADVANCE Investigator Study Group. Broome CM, et al. Lancet. 2023 Nov 4;402(10413):1648-1659. doi: 10.1016/S0140-6736(23)01460-5. Epub 2023 Sep 28. Lancet. 2023. PMID: 37778358 Clinical Trial.
86 results